KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Income from Continuing Operations (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Income from Continuing Operations for 17 consecutive years, with 720000000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 200.59% to 720000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 759900000.0, a 141.2% increase, with the full-year FY2025 number at 759900000.0, up 141.2% from a year prior.
  • Income from Continuing Operations was 720000000.0 for Q4 2025 at Bio-Rad Laboratories, up from 341900000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 3928007000.0 in Q3 2021 to a low of 3367315000.0 in Q1 2022.
  • A 5-year average of 54856300.0 and a median of 87595000.0 in 2023 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 444.51% in 2022, then surged 514.69% in 2024.
  • Bio-Rad Laboratories' Income from Continuing Operations stood at 1565300000.0 in 2021, then surged by 152.88% to 827769000.0 in 2022, then tumbled by 57.75% to 349734000.0 in 2023, then tumbled by 304.67% to 715800000.0 in 2024, then surged by 200.59% to 720000000.0 in 2025.
  • Per Business Quant, the three most recent readings for BIO's Income from Continuing Operations are 720000000.0 (Q4 2025), 341900000.0 (Q3 2025), and 317800000.0 (Q2 2025).